Skip to content
healthcare.dev

Topiramate

NDC 0832-1071, Topiramate, capsule, extended release, from Upsher-Smith Laboratories, LLC.

Product NDC
0832-1071
Status
Listed
Labeler
Upsher-Smith Laboratories, LLC
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA205122
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0832-1071 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOPIRAMATE25 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
0832-1071-1500832107115500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-1071-15)
0832-1071-30008321071301 BOTTLE in 1 CARTON (0832-1071-30) / 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
0832-1071-90008321071901 BOTTLE in 1 CARTON (0832-1071-90) / 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/691d276c-9cc1-4d39-828f-0f44d7ef6328
  • NADAC price for package 00832107130

    GET /v1/drugs/nadac/00832107130

Use it

Look up 0832-1071 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0832-1071 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0832-1071. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.